Nevro Corp Stock Last Dividend Paid

NVRO Stock  USD 4.60  0.02  0.44%   
Nevro Corp fundamentals help investors to digest information that contributes to Nevro Corp's financial success or failures. It also enables traders to predict the movement of Nevro Stock. The fundamental analysis module provides a way to measure Nevro Corp's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Nevro Corp stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Nevro Corp Company Last Dividend Paid Analysis

Nevro Corp's Last Dividend Paid refers to dividend per share(DPS) paid to the shareholder the last time dividends were issued by a company. In its conventional sense, dividends refer to the distribution of some of a company's net earnings or capital gains decided by the board of directors.

Last Dividend

 = 

Last Profit Distribution Amount

Total Shares

More About Last Dividend Paid | All Equity Analysis

Nevro Last Dividend Paid Driver Correlations

Understanding the fundamental principles of building solid financial models for Nevro Corp is extremely important. It helps to project a fair market value of Nevro Stock properly, considering its historical fundamentals such as Last Dividend Paid. Since Nevro Corp's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Nevro Corp's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Nevro Corp's interrelated accounts and indicators.
0.970.86-0.860.890.930.910.981.00.920.820.930.890.890.90.910.340.70.690.720.51
0.970.76-0.80.910.860.910.910.980.950.770.890.810.810.840.830.350.660.670.660.47
0.860.76-0.660.610.810.910.90.860.640.590.790.760.760.730.830.530.740.620.590.71
-0.86-0.8-0.66-0.82-0.82-0.69-0.86-0.83-0.78-0.98-0.87-0.86-0.85-0.95-0.80.08-0.64-0.75-0.94-0.26
0.890.910.61-0.820.850.750.830.890.890.820.820.80.80.840.810.110.470.570.620.21
0.930.860.81-0.820.850.760.940.920.860.810.790.960.960.840.980.20.470.470.610.28
0.910.910.91-0.690.750.760.880.930.780.620.850.690.690.750.760.540.80.740.620.72
0.980.910.9-0.860.830.940.880.970.850.820.920.920.930.920.950.310.70.670.730.52
1.00.980.86-0.830.890.920.930.970.910.790.920.870.870.870.90.380.70.680.680.53
0.920.950.64-0.780.890.860.780.850.910.760.770.820.810.770.820.210.450.470.570.25
0.820.770.59-0.980.820.810.620.820.790.760.840.870.860.910.79-0.120.570.710.90.16
0.930.890.79-0.870.820.790.850.920.920.770.840.810.810.940.80.290.830.840.820.57
0.890.810.76-0.860.80.960.690.920.870.820.870.811.00.870.980.160.460.510.680.19
0.890.810.76-0.850.80.960.690.930.870.810.860.811.00.870.980.160.450.50.670.19
0.90.840.73-0.950.840.840.750.920.870.770.910.940.870.870.850.040.690.760.870.36
0.910.830.83-0.80.810.980.760.950.90.820.790.80.980.980.850.230.470.470.60.27
0.340.350.530.080.110.20.540.310.380.21-0.120.290.160.160.040.230.370.18-0.10.6
0.70.660.74-0.640.470.470.80.70.70.450.570.830.460.450.690.470.370.930.760.86
0.690.670.62-0.750.570.470.740.670.680.470.710.840.510.50.760.470.180.930.860.62
0.720.660.59-0.940.620.610.620.730.680.570.90.820.680.670.870.6-0.10.760.860.38
0.510.470.71-0.260.210.280.720.520.530.250.160.570.190.190.360.270.60.860.620.38
Click cells to compare fundamentals
Many stable companies today pay out dividends to their shareholders in the form of the income distribution, but high-growth firms rarely offer dividends because all of their earnings are reinvested back to the business.
Competition

Based on the recorded statements, Nevro Corp has a Last Dividend Paid of 0.0. This indicator is about the same for the Health Care Equipment & Supplies average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).

Nevro Last Dividend Paid Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Nevro Corp's direct or indirect competition against its Last Dividend Paid to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Nevro Corp could also be used in its relative valuation, which is a method of valuing Nevro Corp by comparing valuation metrics of similar companies.
Nevro Corp is currently under evaluation in last dividend paid category among its peers.

Nevro Corp Current Valuation Drivers

We derive many important indicators used in calculating different scores of Nevro Corp from analyzing Nevro Corp's financial statements. These drivers represent accounts that assess Nevro Corp's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Nevro Corp's important valuation drivers and their relationship over time.
201920202021202220232024 (projected)
Market Cap3.6B5.8B2.8B1.4B774.3M1.4B
Enterprise Value3.7B6.1B3.0B1.5B891.9M1.5B

Nevro Corp ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Nevro Corp's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Nevro Corp's managers, analysts, and investors.
Environmental
Governance
Social

Nevro Fundamentals

About Nevro Corp Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Nevro Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nevro Corp using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nevro Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Pair Trading with Nevro Corp

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Nevro Corp position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nevro Corp will appreciate offsetting losses from the drop in the long position's value.

Moving against Nevro Stock

  0.67ELMD ElectromedPairCorr
  0.54DOCS DoximityPairCorr
  0.5DXCM DexCom Inc Sell-off TrendPairCorr
  0.49OM Outset MedicalPairCorr
  0.45VNRX VolitionrxPairCorr
The ability to find closely correlated positions to Nevro Corp could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Nevro Corp when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Nevro Corp - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Nevro Corp to buy it.
The correlation of Nevro Corp is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Nevro Corp moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Nevro Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Nevro Corp can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Nevro Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Nevro Corp's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Nevro Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Nevro Corp Stock:
Check out Nevro Corp Piotroski F Score and Nevro Corp Altman Z Score analysis.
To learn how to invest in Nevro Stock, please use our How to Invest in Nevro Corp guide.
You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nevro Corp. If investors know Nevro will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nevro Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.87)
Revenue Per Share
11.404
Quarterly Revenue Growth
(0.07)
Return On Assets
(0.09)
Return On Equity
(0.25)
The market value of Nevro Corp is measured differently than its book value, which is the value of Nevro that is recorded on the company's balance sheet. Investors also form their own opinion of Nevro Corp's value that differs from its market value or its book value, called intrinsic value, which is Nevro Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nevro Corp's market value can be influenced by many factors that don't directly affect Nevro Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nevro Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nevro Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nevro Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.